Humana Expands Medicare Advantage Network to Include Northeast Georgia Health System, Longstreet Clinic & Others Across Region

Northeast Georgia Health System (NGHS), a non-profit that cares for more than 1 million people across more than 18 counties, and leading health and well-being company Humana Inc. (NYSE: HUM) have signed an agreement that gives Humana Medicare Advantage members in-network access to medical facilities and physicians at Northeast Georgia Medical Center, Northeast Georgia Physicians Group, Georgia Heart Institute, Longstreet Clinic, Habersham Medical Center and more.

NGHS and members of our HP2 network with Health Partners have been a part of the Humana network for years, and we’re proud to now be a part of the Humana Medicare Advantage plans,” said Steve McNeilly, Chief Operating Officer of Population Health and Vice President of Managed Care for NGHS. “Bringing our patients access to hundreds of doctors at locations across the region is just one more way we’re improving the health of the community in all we do.”

The new agreement, which took effect Sept. 1, 2021, means current Humana Medicare Advantage HMO members now have in-network access to hundreds more physicians across Northeast Georgia. People with Medicare who select a Humana Medicare Advantage plan during the Medicare Annual Election Period, which runs from Oct. 15 to Dec. 7, 2021, will have access beginning Jan.1, 2022.

“We’re thrilled to add more quality medical facilities and health care practitioners like those at NGHS, Longstreet Clinic and others to our Humana network in Northeast Georgia,” said Matthew Moore, Humana Medicare President-Georgia and South Carolina. “We’re looking forward to working together to advance our mission to improve the health and well-being of the members we serve.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”